NeuroServo has developed a brain wave capture device (EEG) that combines the characteristics of being miniaturized, non-intrusive, portable, instant-use, and motion-resistant. The brain waves are analyzed in real time by the NeuroServo algorithms, allowing the early diagnosis of postoperative delirium, a condition affecting 30% to 70% of hospitalized patients aged 65 and over after a major surgery (source: Ely, ICM 2007), dangerous for the patient (permanent cognitive losses) and very expensive for the health system ($16,000 to $64,000 per patient) when diagnosed late.
Currently, delirium is diagnosed with the use of a periodic assessment questionnaire on the patient’s condition and reaction, a method often debated as for its subjectivness and false negative rates.
NeuroServo offers an objective solution that detect delirium after capturing and analyzing the patient’s cerebral wavelengths (E.E.G.). This early detection device of delirium has attracted the attention of internationally recognized neurologists who lead clinical trials just starting in different prestigious hospitals in France.
NeuroServo’s technology is also deployed in a different medical application, in the form of an EEG integrated in a cap, allowing a quick and non-traumatic capture with children in consultation for autistic disorders or AD/HD. The device analyzes the brain waves and determines in real time the patient’s level of attention.
It is currently in clinical study in the Department of Psychiatry of a prestigious children hospital in Canada as a diagnostic, monitoring and potentially intervention tool (for medication) for autistic disorders and AD/HD.